Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the UBS 2018 Global
Healthcare Conference on Tuesday, May 22, 2018, in New York. Charles
Bancroft, executive vice president, Chief Financial Officer and Head
of Global Business Operations, will answer questions about the company
at 11:30 a.m. ET.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media: Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors: Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com